Public Citizen Takes On Propoxyphene Again, This Time Comes Out On Top

The recent advisory committee review of the safety and efficacy of propoxyphene products left FDA with a quandary: the panel voted to remove propoxyphene-containing products from the market, citing little to no efficacy data, but also said their removal would be problematic

More from Archive

More from Pink Sheet